Wednesday, May, 22, 2019 01:22:40

Quest & OncoCare to advance cancer therapy technology in the U.S.

Canadian biopharmaceutical company, Quest PharmaTech Inc., has reportedly announced its entry into a license agreement with OncoCare Therapeutics Inc., a biopharmaceutical company based in Omaha, Nebraska. According to sources, the duo has come together in a bid to develop and commercialize the targeted cancer therapy …

Sysmex, MolecularMD partner for CDx development and commercialization

Japan’s in-vitro diagnostics company, Sysmex Corp. has recently announced a collaboration agreement with U.S. molecular diagnostics firm, MolecularMD Corp., to target challenges in current and future companion diagnostics (CDx) development and commercialization for accelerating precision medicines. As per trusted sources, the non-exclusive collaboration agreement is …

Roche acquires Jecure Therapeutics to develop liver disease drug

Roche, the Swiss drug manufacturer recently acquired the San Diego based startup Jecure Therapeutics for an undisclosed amount. According to sources the recent accrual is meant to help Roche join in the pursuit of discovering new drugs that can cure fatty liver disease. Other pharmaceutical …

Amazon offers software to read medical records and enhance treatments

Amazon is planning to sell a software which would read medical records and give out recommendations to improve treatments or to save money, sources with knowledge on the matter said. Apparently, the software would scan medical files for receiving relevant information, including medical conditions, procedures …

Sun Pharma to buy Japanese company Pola Pharma in a $1 million deal

Renowned Indian multinational pharmaceutical giant Sun Pharmaceutical Industries Ltd. has reportedly announced that it has acquired the Japanese pharmaceutical company, Pola Pharma Inc. in a $1 million deal. Reports cite, Pola Pharma, a part of Pola Orbis group, is primarily involved in manufacturing, research & …